Article
Histiocyte Society blueprint for Langerhans cell histiocytosis research: from cell-of-origin to a more comprehensive cure.
Haematologica - 1 Nov 2025
Pegoraro Francesco, Kondyli Maria, Prudowsky Zachary D, Van Halteren Astrid G S
Abstract excerpt
Langerhans cell histiocytosis (LCH) is a rare myeloid neoplastic disorder driven by tissue-accumulating histiocytes expressing somatic mutations mostly in genes encoding components of the intracellular mitogen-activated protein kinase (MAPK) pathway. Its clinical presentation is highly variable, ranging from self-limiting unifocal lesions to severe, multisystem disease. As a result of new therapeutic strategies,...
Read the complete abstract on PubMedTopics
- Humans
- Histiocytosis, Langerhans-Cell
- Histiocytes
- Mutation
- Disease Susceptibility
